You’ve eliminated dairy. Then gluten. Then anything remotely spicy. And the bloating and stomach pain are still there, waiting for you after nearly every meal. Diet absolutely matters, and so do stress and gut bacteria, but for a meaningful number of people, genetics shapes the gut itself — how reactive its immune lining is and how smoothly its muscles contract. One gene tied to this is TNFSF15, which helps regulate inflammatory signaling in the intestinal lining. A large study of nearly 2,000 people found that a specific TNFSF15 variant was significantly associated with a higher risk of IBS, an effect later confirmed in a meta-analysis pooling multiple study populations (Zucchelli et al., 2011). Genetics is one factor among several here, not the whole explanation.
TNFSF15 and a Gut Lining Primed for Inflammation
TNFSF15 was originally identified as a risk gene for Crohn’s disease, a more severe inflammatory bowel condition, which is what led researchers to test whether it also played a role in IBS, a condition without the visible tissue damage seen in Crohn’s.
What the Research Actually Found
The original discovery study found that the same Crohn’s-associated TNFSF15 variant was linked to a meaningfully higher risk of IBS overall, with a more pronounced effect in the constipation-predominant subtype (Zucchelli et al., 2011). A separate study, however, found the strongest TNFSF15 association specifically in diarrhea-predominant IBS instead (Swan et al., 2013). A later meta-analysis pooling over 2,000 IBS patients and nearly as many controls confirmed the overall TNFSF15 association with IBS risk, even as the precise subtype pattern varied somewhat across the individual studies included (Zhu et al., 2019). The gene’s link to IBS itself looks solid; exactly which symptom pattern it favors is still being worked out.
Why an Immune Gene Shows Up in a “Gut” Condition
TNFSF15 produces a protein involved in modulating the immune response in the gut lining, which helps explain why some IBS looks less like a pure motility problem and more like a low-grade immune issue localized to the intestine. This is also consistent with the well-documented pattern of post-infectious IBS, where symptoms begin after a gastrointestinal infection and never fully resolve.
SCN5A and a Gut That Misfires Electrically
A different and more mechanical piece of the puzzle involves SCN5A, a gene that builds a sodium channel controlling electrical activity in gut smooth muscle and pacemaker cells. This is the same channel responsible for certain heart rhythm disorders, and researchers noticed that some patients with SCN5A-related cardiac arrhythmias also reported IBS symptoms, which prompted a direct investigation.
In a study of 584 people with IBS, researchers found disruptive mutations in SCN5A in about 2.2% of patients, a finding that was independently replicated across four cohorts totaling 1,745 additional people (Beyder et al., 2014). Interestingly, these mutations were more common in constipation-predominant IBS than diarrhea-predominant IBS. In a proof-of-concept case, giving one patient with a disruptive SCN5A mutation a sodium-channel-targeting medication normalized the channel’s function in lab testing and resolved her constipation and abdominal pain (Beyder et al., 2014). This affects only a small slice of people with IBS, but it’s a clear example of a specific, mechanistic genetic cause behind symptoms that otherwise look identical to everyone else’s.
Where the Evidence Falls Short: GNβ3
Not every candidate gene for IBS has held up, and it’s worth being upfront about that. GNβ3, a gene once proposed to influence gut serotonin signaling and studied as a possible IBS risk factor, was included in the same large meta-analysis mentioned above. The pooled analysis found no significant association between the GNβ3 variant and IBS risk (Zhu et al., 2019), despite earlier individual studies suggesting a possible link. This is a useful reminder that not every gene that generates early interest turns out to matter once larger, pooled data becomes available.
What Else Drives Persistent Bloating and Pain
Genetics interacts heavily with gut bacteria, prior infections, food sensitivities, chronic stress, and the gut-brain connection that governs motility and pain sensitivity. Low-grade food intolerances, small intestinal bacterial overgrowth, and disordered eating patterns can all produce symptoms that look identical to genetically-influenced IBS. This is why persistent, unexplained bloating and abdominal pain deserve a proper medical workup rather than an ever-narrowing elimination diet, especially since some genetic causes, like the SCN5A example above, may respond to a specific, targeted treatment rather than a dietary change at all.
Where Genetic Testing Fits In
If you’ve spent years cutting out foods without lasting relief, a comprehensive gut health genetic report can walk through markers like these alongside your broader digestive picture. It won’t diagnose IBS, but it can help you have a more informed conversation with a gastroenterologist about what to investigate next.
Frequently Asked Questions
If I have a genetic variant linked to IBS, will I definitely have symptoms?
No. These variants shift risk rather than guaranteeing the condition, and IBS typically develops from a combination of genetic, dietary, microbial, and stress-related factors.
Can genetic testing tell me which foods are causing my bloating?
Not directly. Genetic testing can point to underlying biological tendencies, like inflammation or gut motility issues, but identifying specific trigger foods usually requires tracking symptoms or working with a doctor or dietitian.
Is IBS all in a person’s gut bacteria, or is it genetic?
Both play a role, and they interact. Genetics can influence how the gut lining responds to bacteria and how sensitive the nervous system is to gut signals, so it’s rarely one factor acting alone.
